astrana health inc. - ASTH

ASTH

Close Chg Chg %
19.45 0.32 1.65%

Closed Market

19.77

+0.32 (1.65%)

Volume: 298.48K

Last Updated:

Feb 19, 2026, 4:00 PM EDT

Company Overview: astrana health inc. - ASTH

ASTH Key Data

Open

$19.37

Day Range

18.74 - 19.83

52 Week Range

18.08 - 39.15

Market Cap

$941.92M

Shares Outstanding

50.16M

Public Float

38.66M

Beta

0.91

Rev. Per Employee

N/A

P/E Ratio

102.37

EPS

$0.19

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

592.50K

 

ASTH Performance

1 Week
 
3.57%
 
1 Month
 
-27.83%
 
3 Months
 
-13.56%
 
1 Year
 
-45.49%
 
5 Years
 
-17.55%
 

ASTH Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 10
Full Ratings ➔

About astrana health inc. - ASTH

Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory. The company was founded by Kenneth Sin and Thomas S. Lam in 1985 and is headquartered in Alhambra, CA.

ASTH At a Glance

Astrana Health, Inc.
1668 South Garfield Avenue
Alhambra, California 91801
Phone 1-626-282-0288 Revenue 2.03B
Industry Services to the Health Industry Net Income 43.15M
Sector Health Services 2024 Sales Growth 46.722%
Fiscal Year-end 12 / 2025 Employees 1,900
View SEC Filings

ASTH Valuation

P/E Current 101.158
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 35.057
Price to Sales Ratio 0.743
Price to Book Ratio 2.12
Price to Cash Flow Ratio 28.98
Enterprise Value to EBITDA 12.748
Enterprise Value to Sales 0.735
Total Debt to Enterprise Value 0.316

ASTH Efficiency

Revenue/Employee 1,070,810.526
Income Per Employee 22,710.00
Receivables Turnover 6.264
Total Asset Turnover 1.746

ASTH Liquidity

Current Ratio 1.746
Quick Ratio 1.746
Cash Ratio 0.795

ASTH Profitability

Gross Margin 11.966
Operating Margin 4.392
Pretax Margin 3.972
Net Margin 2.121
Return on Assets 3.702
Return on Equity 6.504
Return on Total Capital 3.643
Return on Invested Capital 4.149

ASTH Capital Structure

Total Debt to Total Equity 66.203
Total Debt to Total Capital 39.832
Total Debt to Total Assets 34.302
Long-Term Debt to Equity 64.059
Long-Term Debt to Total Capital 38.543
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Astrana Health Inc. - ASTH

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
773.91M 1.14B 1.39B 2.03B
Sales Growth
+12.62% +47.84% +21.19% +46.72%
Cost of Goods Sold (COGS) incl D&A
613.66M 962.23M 1.19B 1.79B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
17.52M 17.54M 17.75M 27.93M
Depreciation
2.12M 3.70M 5.10M 2.30M
Amortization of Intangibles
15.40M 13.84M 12.65M 25.63M
COGS Growth
+10.06% +56.80% +23.61% +50.58%
Gross Income
160.26M 181.94M 197.21M 243.46M
Gross Income Growth
+23.64% +13.53% +8.40% +23.45%
Gross Profit Margin
+20.71% +15.90% +14.22% +11.97%
2021 2022 2023 2024 5-year trend
SG&A Expense
62.08M 77.67M 112.60M 154.11M
Research & Development
- - - -
-
Other SG&A
62.08M 77.67M 112.60M 154.11M
SGA Growth
+26.39% +25.12% +44.97% +36.87%
Other Operating Expense
- - - -
-
Unusual Expense
10.74M 21.27M 4.58M (742.00K)
EBIT after Unusual Expense
87.43M 82.99M 80.03M 90.09M
Non Operating Income/Expense
(4.29M) 11.54M 25.91M 23.82M
Non-Operating Interest Income
1.57M 1.98M 14.21M 14.51M
Equity in Earnings of Affiliates
(4.31M) 5.62M 5.58M 4.45M
Interest Expense
5.39M 7.92M 16.10M 33.10M
Interest Expense Growth
-43.22% +46.83% +103.31% +105.55%
Gross Interest Expense
5.39M 7.92M 16.10M 33.10M
Interest Capitalized
- - - -
-
Pretax Income
77.75M 86.62M 89.84M 80.82M
Pretax Income Growth
-56.43% +11.41% +3.72% -10.04%
Pretax Margin
+10.05% +7.57% +6.48% +3.97%
Income Tax
28.45M 40.88M 31.99M 30.89M
Income Tax - Current - Domestic
34.41M 55.15M 44.43M 35.14M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(5.95M) (14.28M) (12.44M) (4.25M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
(4.31M) 5.62M 5.58M 4.45M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
49.29M 45.74M 57.85M 49.93M
Minority Interest Expense
(24.56M) 570.00K (2.87M) 6.78M
Net Income
73.86M 45.17M 60.72M 43.15M
Net Income Growth
+95.05% -38.84% +34.42% -28.93%
Net Margin Growth
+9.54% +3.95% +4.38% +2.12%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
73.86M 45.17M 60.72M 43.15M
Preferred Dividends
- - - -
-
Net Income Available to Common
73.86M 45.17M 60.72M 43.15M
EPS (Basic)
1.6852 1.0044 1.3042 0.9065
EPS (Basic) Growth
+62.57% -40.40% +29.85% -30.49%
Basic Shares Outstanding
43.83M 44.97M 46.55M 47.60M
EPS (Diluted)
1.6267 0.9905 1.2934 0.8994
EPS (Diluted) Growth
+60.87% -39.11% +30.58% -30.46%
Diluted Shares Outstanding
45.40M 45.60M 46.94M 47.97M
EBITDA
115.70M 121.81M 102.36M 117.28M
EBITDA Growth
+17.04% +5.28% -15.97% +14.57%
EBITDA Margin
+14.95% +10.65% +7.38% +5.76%

Snapshot

Average Recommendation BUY Average Target Price 35.889
Number of Ratings 10 Current Quarters Estimate 0.226
FY Report Date 03 / 2026 Current Year's Estimate 1.345
Last Quarter’s Earnings 0.125 Median PE on CY Estimate N/A
Year Ago Earnings 0.492 Next Fiscal Year Estimate 2.067
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 7 10 5
Mean Estimate 0.23 0.29 1.35 2.07
High Estimates 0.39 0.48 1.98 2.16
Low Estimate 0.08 0.12 0.50 1.92
Coefficient of Variance 47.24 45.57 29.02 4.79

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 7
OVERWEIGHT 1 1 1
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Astrana Health Inc. - ASTH

Date Name Shares Transaction Value
Jan 16, 2026 David G. Schmidt Director 35,763 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $5.79 per share 207,067.77
Jan 16, 2026 David G. Schmidt Director 31,494 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.12 per share 854,117.28
Jan 16, 2026 David G. Schmidt Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Sep 16, 2025 Mitchell W. Kitayama Director 29,060 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $18.2 per share 528,892.00
Sep 16, 2025 Mitchell W. Kitayama Director 21,060 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $30.23 per share 636,643.80
Sep 16, 2025 Mitchell W. Kitayama Director 15,846 Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $30.23 per share 479,024.58
Sep 16, 2025 Mitchell W. Kitayama Director 12,000 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Chan Basho COO and CFO 191,358 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $30.02 per share 5,744,567.16
Mar 28, 2025 Glenn Sobotka Chief Accounting Officer 6,432 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 28, 2025 Glenn Sobotka Chief Accounting Officer 14,701 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Astrana Health Inc. in the News